Table 3.
Comparison between patients according to the requirement for steroidal treatment. Descriptive statistics and one-variable analysis. The percentage is exhibited ignoring missing data.
| Steroids treatment | No n=52 (67.5%) | Yes n=25 (32.5%) | p-value |
|---|---|---|---|
| Age (years, mean ±SD) | 55.8 (±13.8) | 59.7 (±13.3) | 0.143 |
| Gender, male n (%) | 26 (50.0%) | 12 (48.0%) | 0.869 |
| Smoker, n (%) | 17 (34.0%) | 5 (20%) | 0.209 |
| CCI (mean ±SD) | 2.48 (±1.99) | 3.68 (±2.94) | 0.044 |
| FEV1 at diagnosis (mean ±SD) | 89.9 (±18.1) | 77.2 (±18.3) | 0.009 |
| FVC at diagnosis (mean ±SD) | 88.0 (±16.1) | 78.0 (±15.3) | 0.015 |
| Respiratory symptoms n (%) | 28 (53.8%) | 15 (60.0%) | 0.611 |
| Radiological staging: Stage 1 (%) Stage 2 (%) Stage 3 (%) |
18 (34.6%) 31 (59.6%) 3 (5.8%) |
7 (28.0%) 17 (68.0%) 1 (4%) |
0.673 |
| Size of largest TLN (mean ±SD) | 15.2 (±5.3) | 17.2 (±5.6) | 0.129 |
| Location of largest LN measured on CT scan.* Mediastinal node, n | 45 (90.0%) | 20 (83.3%) | 0.411 |
| Extra nodular biopsy, positive n (%) | 20 (66.7%) | 13 (92.9%) | 0.062 |
| Diffuse positive, n (%) | 30 (57.7%) | 7 (28.0%) | 0.015 |
Abbreviations: CCI, Charlson comorbidity index. C-reactive protein. TBB, Transbronchial biopsy. EBB, Endobronchial biopsy. *Mediastinal nodes (2R 2L 4R 4L 7) VS Hilar nodes (10R 10L 11R 11L).